SCHEMBL1268348

SCHEMBL1268348

O=C=C1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11868695 1.00 TRIM24 (0.39)
SCHEMBL11430713 1.00 TRIM24 (0.39)
SCHEMBL11785666 0.96
Cyclopentane SCHEMBL9241252 0.93 ALDH1A1 (0.32)
SCHEMBL2305441 0.81
Benzene SCHEMBL9241241 0.80 CYP1A2 (0.30)
SCHEMBL18695294 0.76
Formic Acid SCHEMBL28500043 0.76
SCHEMBL31607449 0.69 ALDH1A1 (0.35)
SCHEMBL811834 0.69 ALDH1A1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1915149-B1 NOVEL TRIAZOLE DERIVATIVES AS GHRELIN ANALOGUE LIGANDS OF GROWTH HORMONE SECRETAGOGUE RECEPTORS AETERNA ZENTARIS GMBH (DE) 2018-10-10 EP claimed
CN-101272782-B Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors AETERNA ZENTARIS GMBH 2012-03-14 CN claimed
US-7879852-B2 such as (4S)-1-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidine-3-yl]carbonyl}-4-[(4,4-dimethylcyclohexyl)(2,2-dimethylpropanoyl)amino]-N,N-dimethyl-L-prolineamide, used for the treatment of obesity, diabetes, inflammation and erectile dysfunction LG LIFE SCIENCES LTD. (KR) 2011-02-01 US claimed
US-20100331343-A1 NOVEL TRIAZOLE DERIVATIVES AS GHRELIN ANALOGUE LIGANDS OF GROWTH HORMONE SECRETAGOGUE RECEPTORS ZENTARIS GMBH (DE) 2010-12-30 US claimed
US-20090298829-A1 MELANOCORTIN RECEPTOR AGONISTS LG LIFE SCIENCES LTD. (KR) 2009-12-03 US claimed
US-20090042905-A1 TRIAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS AETERNA ZENTARIS GMBH (DE) 2009-02-12 US claimed
CN-101272782-A Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors AETERNA ZENTARIS GMBH (DE) 2008-09-24 CN claimed
WO-2008098977-A1 NOVEL TRIAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS ÆTERNA ZENTARIS GMBH (DE) 2008-08-21 WO claimed
EP-1958631-A1 Novel triazole derivatives as ligands of G-protein coupled receptors AEterna Zentaris GmbH (DE) 2008-08-20 EP claimed
EP-1915149-A2 NOVEL TRIAZOLE DERIVATIVES AS GHRELIN ANALOGUE LIGANDS OF GROWTH HORMONE SECRETAGOGUE RECEPTORS AEterna Zentaris GmbH (DE) 2008-04-30 EP claimed
US-20070208061-A2 NOVEL TRIAZOLE DERIVATIVES AS GHRELIN ANALOGUE LIGANDS OF GROWTH HORMONE SECRETAGOGUE RECEPTORS ZENTARIS GMBH (DE) 2007-09-06 US claimed
EP-1757290-A1 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors Zentaris GmbH (DE) 2007-02-28 EP claimed
WO-2007020013-A2 NOVEL TRIAZOLE DERIVATIVES AS GHRELIN ANALOGUE LIGANDS OF GROWTH HORMONE SECRETAGOGUE RECEPTORS ÆTERNA ZENTARIS GMBH (DE) 2007-02-22 WO claimed
US-20070037857-A1 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors ZENTARIS GMBH (DE) 2007-02-15 US claimed
EP-0961787-B1 (CO)POLYMERS BY PHOTOPOLYMERIZATION CIBA SC HOLDING AG (CH) 2002-05-22 EP claimed
US-6251962-B1 ACRYLATE POLYMER CIBA SPECIALTY CHEMICALS CORPORATION 2001-06-26 US claimed
EP-0961787-A1 (CO)POLYMERS BY PHOTOPOLYMERIZATION Ciba SC Holding AG (CH) 1999-12-08 EP claimed
WO-1998037105-A1 (CO)POLYMERS BY PHOTOPOLYMERIZATION CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 1998-08-27 WO claimed
WO-2024108198-A2 METHODS OF TREATING OBESITY WITH AN MC4R AGONIST RHYTHM PHARMACEUTICALS, INC. (US) 2024-05-23 WO disclosed
US-3914313-A Method for the production of cyclopentamethylene ketene SNIA VISCOSA 1975-10-21 US disclosed